UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by O Keefe Stevens Advisory Inc.

O Keefe Stevens Advisory Inc. cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 19.8% during the fourth quarter, HoldingsChannel.com reports. The fund owned 400 shares of the healthcare conglomerate’s stock after selling 99 shares during the quarter. O Keefe Stevens Advisory Inc.’s holdings in UnitedHealth Group were worth $212,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also modified their holdings of the business. CoreCap Advisors LLC grew its position in shares of UnitedHealth Group by 0.5% during the second quarter. CoreCap Advisors LLC now owns 4,217 shares of the healthcare conglomerate’s stock worth $2,166,000 after acquiring an additional 19 shares during the last quarter. Elgethun Capital Management grew its position in UnitedHealth Group by 0.3% in the 2nd quarter. Elgethun Capital Management now owns 6,577 shares of the healthcare conglomerate’s stock valued at $3,369,000 after buying an additional 19 shares during the last quarter. Hollencrest Capital Management grew its position in UnitedHealth Group by 0.8% in the 3rd quarter. Hollencrest Capital Management now owns 2,337 shares of the healthcare conglomerate’s stock valued at $1,180,000 after buying an additional 19 shares during the last quarter. Smith Salley & Associates grew its position in UnitedHealth Group by 0.7% in the 3rd quarter. Smith Salley & Associates now owns 2,873 shares of the healthcare conglomerate’s stock valued at $1,451,000 after buying an additional 19 shares during the last quarter. Finally, MFA Wealth Advisors LLC grew its position in UnitedHealth Group by 4.8% in the 3rd quarter. MFA Wealth Advisors LLC now owns 414 shares of the healthcare conglomerate’s stock valued at $209,000 after buying an additional 19 shares during the last quarter. 86.31% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Down 0.5 %

Shares of UNH stock opened at $469.50 on Friday. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 0.67. The company has a market capitalization of $437.97 billion, a price-to-earnings ratio of 22.16, a PEG ratio of 1.30 and a beta of 0.69. The firm has a 50-day moving average price of $483.26 and a 200 day moving average price of $510.78. UnitedHealth Group Incorporated has a twelve month low of $449.70 and a twelve month high of $558.10.

UnitedHealth Group (NYSE:UNH – Get Rating) last posted its quarterly earnings results on Friday, January 13th. The healthcare conglomerate reported $5.34 EPS for the quarter, beating the consensus estimate of $5.17 by $0.17. The company had revenue of $82.79 billion during the quarter, compared to analysts’ expectations of $82.53 billion. UnitedHealth Group had a return on equity of 27.04% and a net margin of 6.21%. The firm’s revenue was up 12.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $4.48 EPS. Research analysts forecast that UnitedHealth Group Incorporated will post 24.91 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 21st. Stockholders of record on Monday, March 13th will be issued a dividend of $1.65 per share. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.41%. The ex-dividend date is Friday, March 10th. UnitedHealth Group’s payout ratio is currently 31.15%.

Analyst Ratings Changes

UNH has been the subject of a number of recent analyst reports. Stephens reissued an “overweight” rating and issued a $605.00 target price on shares of UnitedHealth Group in a report on Tuesday, February 28th. StockNews.com raised UnitedHealth Group from a “buy” rating to a “strong-buy” rating in a report on Saturday, March 11th. Credit Suisse Group raised their target price on UnitedHealth Group from $590.00 to $610.00 and gave the company an “outperform” rating in a report on Wednesday, December 7th. Loop Capital raised their target price on UnitedHealth Group from $575.00 to $590.00 in a report on Tuesday, January 17th. Finally, UBS Group cut their price target on UnitedHealth Group from $590.00 to $550.00 and set a “neutral” rating for the company in a research note on Wednesday, January 18th. Three investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average target price of $599.68.

UnitedHealth Group Profile

(Get Rating)

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.